FindMyKOL
Clinical trialNCT01762124CompletedInterventional

Study of the Native Outflow Tract Transcatheter Pulmonary Valve (TPV)

NCT01762124 is an interventional trial sponsored by Medtronic Heart Valves. As of 21 Nov 2026, it is completed. It studies Congenital Heart Disease and Tetralogy of Fallot. The registry lists an enrollment of 20 participants at 3 sites in 2 countries. The registry lists a start date of 31 Oct 2012 and a primary completion date of 31 May 2015. One of its registered investigators has a FindMyKOL profile.

SponsorMedtronic Heart Valves →Enrollment20Congenital Heart DiseaseTetralogy of Fallot
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01762124
FieldValue
Registry IDNCT01762124
StatusCompleted
Study typeInterventional trial
Lead sponsorMedtronic Heart Valves
Enrollment20
Registered sites3
Countries2
ConditionsCongenital Heart Disease and Tetralogy of Fallot
Start31 Oct 2012
Primary completion31 May 2015
Study completion31 Jul 2020
Last update posted7 Aug 2020

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this early feasibility study is to determine how a new transcatheter pulmonary valve will move and perform once implanted in the right ventricular outflow tract.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Massachusetts, United States1 site
  • Boston Children's Hospital

    Boston

Ohio, United States1 site
  • Nationwide Children's Hospital

    Columbus

Canada1 site
  • the Hospital for Sick Children

    Toronto, Ontario

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusetts: 1 siteMA1Rhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhio: 1 siteOH1PennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Outside the United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT01762124

Each answer restates registry values shown on this page.

What is NCT01762124?

NCT01762124 is an interventional trial sponsored by Medtronic Heart Valves. It studies Congenital Heart Disease and Tetralogy of Fallot.

Who leads NCT01762124?

The registry names John P. Cheatham, MD (principal investigator, Nationwide Children's Hospital), Lee Benson, MD (principal investigator, The Hospital for Sick Children, Toronto, Canada) and Lisa Bergersen, MD, MPH (principal investigator, Boston Children's Hospital, Boston, Massachusetts, USA) as overall officials.

Where does NCT01762124 run?

The registry lists 3 sites in 2 countries. Most sites are in these countries: United States (2) and Canada (1).

When did NCT01762124 end?

The registry lists a primary completion date of 31 May 2015 and a study completion date of 31 Jul 2020. The sponsor last updated the record on 7 Aug 2020.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.